Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Samuel R. Saks currently holds 14,000 shares of JAZZ PHARMACEUTICALS INC (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel R. Saks has been a net buyer of JAZZ stock. They have purchased $560.2K and sold $0 worth of shares.
Samuel R. Saks's most recent insider trade was on Feb 26, 2021, when they sold 12,000 shares at $0.00 per share.
Samuel R. Saks serves as Executive at JAZZ PHARMACEUTICALS INC (JAZZ). They have executed 41 insider transactions totaling $560.2K over their tenure at the company.
Samuel R. Saks holds the position of Executive at JAZZ PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Samuel R. Saks has shown a buying trading pattern, with $560.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Samuel R. Saks was on Jun 2, 2016, when they purchased $250.0K worth of PDLI shares. This transaction involved 71,023 shares at $3.52 per share.
Samuel R. Saks currently owns 14,000 shares of JAZZ PHARMACEUTICALS INC (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Samuel R. Saks's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Samuel R. Saks has 41 Form 4 filings on record as an insider at JAZZ PHARMACEUTICALS INC.
Set alerts for Samuel R. Saks and 40,000+ other insiders.